Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Overweight on Samsara, Lowers Price Target to $17

Morgan Stanley Maintains Overweight on Samsara, Lowers Price Target to $17

Morgan Stanley analyst Keith Weiss maintains Samsara (NYSE:IOT) with a Overweight and lowers the price target from $18 to $17.

byBenzinga Newsdesk

November 22, 2022

1 minute read

Morgan Stanley analyst Keith Weiss maintains Samsara (NYSE:IOT) with a Overweight and lowers the price target from $18 to $17.

Analyst Ratings

Where Unum Gr Stands With Analysts

By Benzinga Insights

August 9, 11:00 AM

Over the past 3 months, 8 analysts have published their opinion on Unum Gr (NYSE:UNM) stock. These analysts…

UNM

RBC Capital Upgrades Rollins to Outperform, Announces $40 Price Target

By Benzinga Newsdesk

September 6, 5:01 AM

RBC Capital analyst Ashish Sabadra upgrades Rollins (NYSE:ROL) from Sector Perform to Outperform and announces $40 price target.

ROL

Movers
News

What’s Going On With T2 Biosystems Stock Now?

By Erica Kollmann

October 24, 1:09 PM

T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher Tuesday, though the stock remains down by more than 75% over the last month. What To Know:

TTOO

United States Steel Loses Bidder Esmark Amid Pressure From Union Workers

By Lekha Gupta

August 24, 9:31 AM

Industrial conglomerate Esmark has reportedly backed out of bidding for the acquisition of United States Steel Corp (NYSE: X).

CLF

Morgan Stanley Maintains Overweight on Samsara, Lowers Price Target to $17

Related Posts

Where Unum Gr Stands With Analysts

RBC Capital Upgrades Rollins to Outperform, Announces $40 Price Target

What’s Going On With T2 Biosystems Stock Now?

United States Steel Loses Bidder Esmark Amid Pressure From Union Workers